Clinical Trials Browser

Withdrawn × Recurrence × midostaurin × Clear all

NCT03207334 2018-10-22

iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)

Phase 2 Withdrawn

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute